Product Description: HBV-IN-39-d3 (Example 14) is a deuterated HBV-IN-39 (Example 13). HBV-IN-39 is an HBV inhibitor. HBV-IN-39-d3 has better oral bioavailability than HBV-IN-39[1].
Applications: COVID-19-anti-virus
Formula: C23H25D3FNO6
References: [1]Yi Chen, et al. Therapeutic agents for the treatment of HBV infection. Patent CN110240596B.